The catenin ARVCF is a member of the p120 ctn subfamily of Armadillo proteins. A number of catenins directly bind cadherin cytoplasmic tails, contributing to the modulation of cell-cell adhesion and motility processes. Some catenins, such as ␤-catenin (and likely p120 ctn ), have additional roles within signaling pathways regulating gene transcription. We have isolated the Xenopus homolog of human ARVCF. Utilizing the cadherin membrane proximal region known to bind p120 ctn and ␦-catenin, coimmunoprecipitation experiments demonstrate that Xarvcf, likewise, binds cadherin in this region and that corresponding point mutations within conserved residues abrogate the Xarvcfcadherin association. Western blot analysis of Xarvcf protein across a series of developmental stages reveals changes in protein mobility, likely due to changes in phosphorylation. Xarvcf is a maternally provided transcript and expressed in the embryo throughout all stages of development. Interestingly, Xarvcf mRNA is differentially spliced to produce several isoforms, one of which is developmentally regulated. In common with the putative post-translational modifications of the Xarvcf protein, the presence of alternative splice isoforms suggests that Xarvcf possesses the capacity to effect developmental functions in a regulatable manner.
Intercellular junctions have classically been viewed as macromolecular assemblies essential for the formation of embryonic tissues and their later maintenance in the adult, for example, the early organization and subsequent mature polarization of neural and epithelial cells (respectively, expressing N-and E-cadherins) (1) . Importantly, emerging evidence has indicated that the proteins that constitute these junctions, such as components of the cadherin-catenin complex, promote cell-cell communication and intracellular signaling in a manner that is intimately interdependent with their structural roles (2) . For example, morphogenetic events occurring during embryonic development, which include vast cell migrations, require that cellular junctions be highly dynamic. Similarly, in the adult, processes such as wound repair must take place with expedience and precision, regenerating intercellular junctions and hence intercellular "relationships" characteristic of that tissue. Failures within embryonic or adult junctional structures is associated with grave pathologies, including birth defects and cancer, made evident in reduced cellular "identity"/ differentiation and increased cell aggressiveness as reflected in heightened cell motility, invasion, and metastasis (3) (4) (5) . Thus, the means by which junctional complexes are modulated in both health and disease constitutes an area of considerable interest. We are interested in the roles that catenins play in regulating cadherin cell-cell adhesive/motility function, and in this report focus on Xenopus ARVCF 1 (Xarvcf). The cadherin proteins comprise a family of transmembrane receptors that mediate cell-cell adhesion via the calcium-dependent homophilic binding of their extracellular domains. Although classical cadherins possess extracellular domains capable of engaging in weak adhesive activity in the absence of the cytoplasmic domain, full "adhesive strengthening" requires intact cadherin protein (6, 7) . The cytoplasmic domain of classical cadherins contains two highly conserved regions that directly bind other proteins termed catenins. Catenins associate in turn with multiple other signaling and structural components, including kinases, phosphatases, and actin-associated proteins, together forming a complex higher order structure that is presently only partially understood (8, 9) . Crucial components of the cadherin cell-cell adhesion complex include ␤-catenin or plakoglobin (␥-catenin), which bind in a mutually exclusive manner to the distal portion of the cadherin cytoplasmic domain and thereby link cadherin to ␣-catenin, ␣-actinin, and the cortical actin-cytoskeleton. This indirect association of cadherin with the actin-cytoskeletal network appears pivotal in modulating cadherin adhesive capacity, with increased cadherin-cytoskeletal association correlating with increased cadherin adhesive function (7, 10) .
Independent of the indirect association of the distal cytoplasmic domain of cadherin with the cortical actin cytoskeleton, recent work has indicated that the juxtamembrane region of the cadherin cytoplasmic tail is likewise critical to cadherin adhesive function (11) . Although published studies are not in complete agreement, a consensus appears to exist that the juxtamembrane region directly or indirectly contributes to modulating (positively, negatively, or both) lateral cadherin dimerization/clustering within the plasma membrane plane, and that such lateral organization is an important determinant of adhesive interactions with similarly organized cadherins presented from neighboring cells (12) (13) (14) . The identification and characterization of protein factors binding cadherin juxtamembrane domains, therefore, is believed to be crucial in understanding the physiologic or pathologic modulation of cadherin-based adhesion. In this regard, some members of a subset of the Armadillo protein family, the p120 ctn subfamily, have already been shown to bind the cadherin juxtamembrane region (13, (15) (16) (17) , and indeed, the interaction of at least one of these proteins, p120
ctn , appears to alter cadherin-based adhesion (14, 18 -20) .
All members of the Armadillo protein family are characterized by a central domain containing repeats of 40 -42 amino acids important for protein-protein interactions (21) . The founding member of this family, Armadillo, was first identified and characterized in the segmental patterning of the early Drosophila embryo (22, 23) . Subsequently, the vertebrate ortholog of Armadillo, ␤-catenin, was isolated in direct association with cadherin (24) , and surprisingly, additionally found to transduce Wnt signals (25) in nuclear association with transcription factors of the LEF/TCF family (26, 27) .
The growing p120 ctn subfamily includes p120 ctn (28, 29) , p0071 (30), ␦-catenin (or NPRAP: neural plakophilin-related arm-protein) (31, 32) , plakophilins 1-3 (33-37), and ARVCF: Armadillo repeat gene deleted in velocardiofacial syndrome (38) . The p120 ctn subfamily is distinguished from other Armadillo family members by the number and organization of the Armadillo repeats, exonic organization, and the presence of multiple isoforms, which result from differential mRNA splicing (39, 40) . The Armadillo domain of p120 ctn subfamily members is composed of 10 imperfect Armadillo repeats (␤-catenin and plakoglobin, in contrast, possess 12.5 repeats), with spacer sequences following repeats 4, 5, and 6. Thus far, all p120 ctn subfamily members localize to adherens junctions or desmosomes, and, of further interest, all have additionally been detected within the nucleus. In this regard, p120 ctn was recently found to bind a novel POZ zinc finger transcription factor, Kaiso (41) . A role of p120 ctn in regulating cadherin-mediated adhesion together with possible nuclear functions is reminiscent of ␤-catenin, however, the specific contributions of p120 ctn to nuclear processes, including transcriptional regulation, are not yet clear.
Proposed functions of the cadherin juxtamembrane domain have generated considerable interest even while published results have not been in complete accordance. For example, although the juxtamembrane region of C-cadherin appears to be required for its lateral clustering (13) and can support clustering and adhesion for VE-cadherin (10) , that of E-cadherin has been reported to either likewise facilitate (20) or reduce cadherin dimerization/adhesive function (12, 14, 18) .
Complementing the examination of the cadherin juxtamembrane region in the positive and/or negative modulation of cadherin dimerization, clustering, and adhesion, attention has focused upon directly associated p120 ctn family members. For example, E-cadherin constructs containing site-directed mutations in the juxtamembrane region abrogate its association with p120 ctn (but not with ␤-catenin), and in contrast to native E-cadherin, fail to confer strong adhesive activity when transfected into cadherin-deficient cells (20) . Thus, in this case, the capacity of p120 ctn to associate with the juxtamembrane region of cadherin was positively associated with cadherin adhesive capacity. Other studies, including earlier work from our group, have indicated that p120 ctn expression is capable of reducing cadherin-mediated adhesion (14, 18, 19) . Although a limited number of studies appear difficult to reconcile, synthesis may be approached if one accepts the possibility that p120 ctn imposes both positive and negative effects upon cadherin adhesive function. Indeed, the validity of such a view has been heightened by recent findings suggesting that the phosphorylation of specific residues within the N-terminal domain of p120 ctn (14, 18) determines the extent to which p120 ctn promotes or inhibits cadherin adhesive function, speculatively via differential capacities to recruit unknown cofactors.
The juxtamembrane region of cadherin binds additional factors distinct from p120 ctn , but which still belong to the p120 ctn subfamily of Armadillo proteins. For example, ␦-catenin/ NPRAP is a p120 ctn subfamily member that likewise binds cadherin juxtamembrane regions via its central Armadillo domain (17) . Intriguingly consistent with its primary expression in neural tissue (31, 32) and perhaps with its purported role in modulating cadherin function (17) , hemizygosity for ␦-catenin is correlated with severe mental retardation in humans (42) . On the cellular level, ␦-catenin appears to share some features with p120 ctn , for example, ␦-catenin's ectopic expression in Madin-Darby canine kidney cells induces cell shape changes and increases cell scattering in response to the addition of hepatocyte growth factor (17) . In addition, ␦-catenin localizes to the nucleus, although in contrast to p120 ctn (or ␤-catenin), nuclear (transcriptional?) cofactors have not yet been discerned (17) .
The ARVCF protein was identified on the basis of primary sequence similarity to known p120 ctn family members (38) . Of the Armadillo proteins, ARVCF is most closely related to p120 ctn , sharing significant homology within the central Armadillo domain (55% identity), and even within the generally more divergent N and C termini (respectively, 42% and 31% identity). Interestingly, the ARVCF gene was found to reside within a chromosomal region deleted in velocardiofacial syndrome, a human syndrome characterized by multiple congenital abnormalities, including cleft palate and heart defects, and indicative of underlying failures in neural crest cell migration (38) . Recently, Mariner et al. (43) reported that ARVCF and p120 ctn compete for binding to E-cadherin, consistent with the idea that ARVCF also binds the the juxtamembrane domain of cadherins.
In the present work, we report the cloning of the Xenopus ortholog of human ARVCF, which we name Xarvcf. The use of alternative start codons and differential splicing of the transcript produces several isoforms, some of which were revealed to be temporally and spatially regulated during development. Furthermore, we were interested to observe shifts in the electrophoretic mobility of Xarvcf protein during gastrulation, likely due to changes in its phosphorylation. We demonstrate that, in common with p120 ctn and ␦-catenin, Xarvcf binds the juxtamembrane region of C-cadherin and that this association is abolished following site-directed mutagenesis of C-cadherin's juxtamembrane region. Thus, Xarvcf joins p120 ctn and ␦-catenin as a p120 ctn subfamily member binding the cadherin membrane proximal region and possessing various isoforms, and more speculatively, modulating cadherin-dependent adhesive strength via effects on cadherin dimerization/clustering.
EXPERIMENTAL PROCEDURES
cDNA Cloning-A short fragment of Xarvcf cDNA was amplified from a Xenopus stage 17 cDNA library (44) using degenerate primers (5Ј GAY CAY CCI AAR AAR GAR GTI CA 3Ј (mouse aa DHPKKEVHI) and 5Ј GCG AAT TCR CAN ACR CAR TTY TCN AC 3Ј (mouse aa DKS-VENCV)) corresponding to a region within the central Armadillo repeat domain of mouse p120
ctn (28) . PCR conditions used an annealing temperature of 50°C and 35 cycles. The 488-bp sequence was then used to design primers for amplification of the full-length cDNA sequence from a Xenopus oocyte stage cDNA library (Xenopus MATCHMAKER cDNA library, pGAD10 vector, CLONTECH). This was accomplished using anchored PCR (45) , which utilizes vector-specific primers and genespecific primers to amplify unknown sequence, and by applying RACE of oocyte mRNA using the Marathon cDNA amplification kit (CLON-TECH). Once the entire coding sequence was identified, a full-length cDNA for each isoform was generated from the cDNA library by PCR with Expand High Fidelity PCR system (Roche Molecular Biochemicals) or by PCR of cDNA reverse-transcribed (Moloney murine leukemia virus, Life Technologies, Inc.) using poly(T)20 primers and 1 g of total oocyte RNA. The product for each isoform was gel-purified using a QIAquick gel extraction kit (Qiagen) and subcloned into the TA vector (Invitrogen) and sequenced.
The primers used for Xarvcf-1B, Xarvcf-1AB, Xarvcf-2B, Xarvcf-2AB were as follows. ATG-1: 5Ј-ATAGATGCCTGCCGAACTC-3Ј, ATG-2: 5Ј-ATGATGCAGGAACCTCCAGAAATGC-3Ј, with A insert: 5Ј-TTAGAC-CCAGGAGTCAACAGGCTG-3Ј, without A insert: 5Ј-GGTCTTCCCAA-AAAGGGTCACTGC-3Ј.
Protein motifs were identified using the program PPSEARCH/Prosite found on the Web. Protein and cDNA alignments utilized the ClustalW algorithm (46) .
C-cadherin JMR Constructs-To localize the C-cadherin JMR construct to the plasma membrane via its N terminus, the c-src myristylation motif MGSSKSKPKD (47) was inserted upstream of the myc epitope tag (MT) at the BamHI and ClaI sites in the pCS2ϩMT vector (48) . This was done using the oligonucleotides: 5Ј GAT CCG CCG CCA CCA TGG GAT CGT CTA AGT CGA AGC CTA AGG ATC AT 3Ј and 5Ј CGA TGA TCC TTA GGC TTC GAC TTA GAC GAT CCC ATG GTG GCG GCG 3Ј. JMR-Myr.MT constructs were made through the insertion of C-cadherin aa 744 -808 into the ClaI site using the PCR primers 5Ј CCA TCG ATG GAA GAG AAA GAA G 3Ј and 5Ј CCA TCG ATG TGG GGC AGG CAT 3Ј. JMR-MT without the myristylation motif was constructed by subcloning the JMR into the BamHI and ClaI sites of pCS2ϩMT using the primer pair 5Ј CGG GAT CCA GAT GAA GAG AAA GAA G 3Ј and 5Ј CCA TCG ATG TGG GGC AGG CAT 3Ј.
To generate the JMRGA mutant constructs, PCR-mediated mutagenesis was utilized to change glycines 771, 772, and 773 to alanine, employing the PCR primer pair 5Ј GAG GAA GCT GCA GCA GAG GAG 3Ј and 5Ј CTC CTC TGC TGC AGC TTC CTC 3Ј.
RNA Purification, Northern Blot Analysis, and RT-PCR-Total RNA was isolated from embryos using the phenol/guanidine isothiocyanatebased reagent Trizol (Life Technologies, Inc.), and mRNA was purified using an mRNA purification kit (Amersham Pharmacia Biotech), each according to the manufacturer's instructions.
For Northern blots, total RNA was separated on formaldehyde/agarose gels, transferred to a Hybond-Nϩ membrane (Amersham Pharmacia Biotech) employing the PosiBlot 30-30 Pressure Blotter (Stratagene), and subsequently UV-X-linked to the membrane. The Xarvcf probe was random prime-labeled with [ 32 P]dCTP using Ready-To-Go DNA labeling beads (Amersham Pharmacia Biotech). Ultrahyb (CLON-TECH) was used for blocking and hybridization.
For detection of transcripts by PCR, cDNA was generated from 1 g of total RNA using Moloney murine leukemia virus reverse transcriptase or Superscript (Life Technologies, Inc.), employing random hexamers (Roche Molecular Biochemicals) or poly(T)20 oligo. The RT-PCR assays were semiquantitative. The linear range for each primer set was determined by removing 5-l aliquots from the PCR reaction tube at 5-cycle intervals and comparing band intensities of the products run out in an agarose gel. For reactions producing two bands, the cycle number that allowed the detection of the band present at lower levels was utilized.
N-terminal isoforms: 57°C, 30 cycles, 5Ј-ATAGATGCCTGCCGAAC-TC-3Ј, 5Ј-TTAATCCCCGAGACAGGCTGC-3Ј; C-terminal isoforms: 53°C, 30 cycles, 5Ј-GATGACAGCACACTACCATTGG-3Ј, 5Ј-GGTCTT-CCCAAAAAGGGTCACTGC-3Ј; all transcripts: 65°C, 25 cycles, 5Ј-GC-TTGTGGAGCACTGCGGAACA-3Ј, 5Ј-GCAAAGCATCCACTAGCCCG-TC-3Ј; controls: ODC: 55°C, 24 cycles, 5Ј-GGAGCTGCAAGTTGGAGA-3Ј, 5Ј-CTCAGTTGCCAGTGTGGTC-3Ј (64); EF1␣: 55°C, 25 cycles, 5Ј-CAGATTGGTGCTGGATATGC-3Ј, 5Ј-ACTGCCTTGATGACTCC-TAG-3Ј.
Antibodies-Xarvcf peptides SNIDLNRSQPERFQ(C) (aa 204 -217) and EDSKPRDAEWSTVF(C) (aa 471-484) were synthesized by the Synthetic Antigen Core Facility at M. D. Anderson Cancer Center. Peptides (C)YGLEDDNRSLGADD (aa 221-234) and (C)LRNISYGKD-NENKV (aa 389 -402) were synthesized by Genosys. The four peptides were conjugated to keyhole limpet hemacyanin facilitated by the presence of an added cysteine residue to the N or C termini of the peptide. Rabbits were immunized with a mixture of the four keyhole limpet hemacyanin-linked peptides, and the preimmune and immune sera tested against exogenously expressed HA-tagged Xarvcf protein and endogenous Xarvcf in Xenopus embryo extracts. The anti-peptide antibodies were affinity-purified with the same peptides covalently bound to cyanogen bromide-activated Sepharose, according to the manufacturer's instructions (Sigma). The affinity-purified antibody was again tested against both exogenous HA-tagged Xarvcf and endogenous Xarvcf.
A polyclonal antibody was also generated against full-length Xarvcf, using the Xarvcf-2B isoform to avoid the induction of isoform-specific antibodies. Xarvcf-2B was subcloned into the pQE32 vector (QIAexpress System, Qiagen) with N-terminal 6xHis tag by adding PCRgenerated XhoI restriction sites on both ends and ligating into the compatible ends of the SalI site of pQE-32. The 6xHis-Xarvcf-2B fusion protein was expressed and purified using Ni-NTA matrices according to the manufacturer's instructions (Qiagen). Two rabbits were immunized with full-length Xarvcf-2B-6xHis fusion protein, and the preimmune and immune sera were tested against endogenous and exogenous HAtagged Xarvcf.
Embryos-Xenopus eggs were obtained and fertilized using standard methods (49) , dejellied with 2% cysteine HCl (pH 8.0), rinsed, and incubated in 0.1ϫ MMR (1ϫ MMR: 10 mM NaCl, 0.2 mM KCl, 0.1 mM MgSO 4 , 0.2 mM CaCl 2 , 0.5 mM HEPES, pH 7.4). Embryos were placed in 1ϫ MMR with 4% Ficoll and injected with mRNA at two-cell or four-cell embryo stages. Injected embryos were transferred to 0.1ϫ MMR with antibiotics and cultured between 14 and 18°C. Embryos were staged according to the normal table of Xenopus laevis development (50) .
For expression in Xenopus embryos, the full-length Xarvcf cDNA isoforms were subcloned by PCR (Expand High Fidelity PCR system, Roche Molecular Biochemicals) into the XbaI restriction site of the expression vector pCS2ϩ3HA. Capped mRNAs were synthesized in vitro from linearized plasmids (NotI restriction enzyme, New England BioLabs) using the SP6 mMessage mMachine kit (Ambion). Injections were performed using the oil-based NA-1 microinjector (Sutter).
Western Blotting and Immunoprecipitations-Whole embryo lysates for Western blots were prepared by homogenizing in 15 mM Tris, pH 6.8, supplemented with protease and phosphatase inhibitors, extracted with 1,1,2-trichlorotrifluoroethane (Freon), and centrifuged at 13,300 rpm for 30 min to remove yolk protein from the lysates (51). The protease inhibitor mixture consisted of 1 mM phenylmethylsulfonyl fluoride, 4 g/ml aprotinin, 1 g/ml pepstatin A, 2 g/ml leupeptin, 10 g/ml antipain, 50 g/ml benzamidine, 10 g/ml soybean trypsin inhibitor, 100 g/ml iodoacetamide, and 40 g/ml 1-chloro-3-tosylamido-7-amino-2-heptanone. The phosphatase inhibitor mixture consisted of 100 nM okadaic acid, 100 nM calyculin A, 50 nM tautomycin, and 2.5 mM vanadate with 0.1% H 2 O 2 .
For immunoprecipitation of Xarvcf-HA, C-cadherin-MT or the various C-cadherin JMR-MT constructs, embryos were lysed using R buffer (10 mM Tris, pH 7.4, 0.5% Nonidet P-40, 150 mM NaCl, 1 mM EDTA, 1 mM NaVO 3 , 1 g/ml pepstatin, 2 g/ml leupeptin, 4 g/ml aprotonin, 10 g/ml antipain, and 70 g/ml phenylmethylsulfonyl fluoride) and a Teflon homogenizer. Lysates were then centrifuged at 13,300 rpm for 30 min. Immunoprecipitations from the cleared lysate were conducted using anti-MT (9E10) or anti-HA (12CA5) monoclonal antibodies added at 1:1000 dilution. Samples were rotated at 4°C for 2-3 h, protein Aand G-Sepharose beads were added (Sigma), and rotated an additional hour followed by a low speed centrifugation. The beads were then washed with 3 ϫ 1 ml of lysis buffer and 1 ϫ 1 ml of 10 mM Tris, pH 7.4.
Proteins were separated on 8% SDS-polyacrylamide gels and electrophoretically transferred to nitrocellulose membranes. For standardization between samples, each immunoprecipitation sample lane contained five embryo equivalents and whole cell lysate lanes contained the equivalent of one embryo. Endogenous Xarvcf was detected by Western blotting using anti-Xarvcf polyclonal antibodies (1:250 for peptide antibody, 1:5000 for protein antibody). C-cadherin was Westernblotted with the anti-C-cadherin polyclonal antibody (1:10,000 dilution). Epitope-tagged proteins were Western-blotted with anti-HA monoclonal antibody (1:1000 dilution) or anti-Myc monoclonal antibody (1:1000 dilution). Proteins were detected with enhanced chemiluminescence (ECL, Amersham Pharmacia Biotech) using goat anti-rabbit IgG or goat anti-mouse IgG (1:7000 dilution) secondary antibodies coupled to horseradish peroxidase (Bio-Rad).
RESULTS
Xarvcf cDNA Isolation and Isoform Characterization-To isolate cDNA sequence(s) of p120 ctn subfamily members in Xenopus, degenerate PCR primers based upon the mouse p120 ctn cDNA sequence generated a 488-bp fragment of Xenopus ARVCF (Xarvcf). The full-length clone was obtained by applying anchored PCR (45) upon Xenpous oocyte cDNA, and subsequently 3Ј RACE employing oocyte mRNA. The merged cDNA sequences obtained indicated an open reading frame of 2607 bp (869 aa), followed by a short 80-bp 3Ј-untranslated region harboring a polyadenlyation signal residing 14 bp upstream of the poly(A) tail.
Because alternative splicing has been reported for most p120 ctn subfamily members, several full-length cDNA clones of Xarvcf were sequenced in corresponding regions, thereby resolving three differentially spliced regions within its structure. First, differential splicing was detected within Xarvcf's coding sequence directing the use of two alternative translation start sites (Fig. 1A) . Use of the upstream translational start site requires the removal of sequence containing in-frame stop codons residing between it and the second start site, and results in the synthesis of 18 additional amino acids of overall acidic character (pI ϭ 3.4). Fig. 1B depicts the N-terminal alignment of Xarvcf, human ARVCF, and human p120 ctn . Xarvcf's first translation start site aligns with the second site reported for human ARVCF, whereas Xarvcf's second translational start site aligns with the third site noted for human p120 ctn (Fig. 1B) . Use of a translational start site in human ARVCF corresponding to the second we discerned in Xarvcf was not reported, whereas sequence homologous to the first site within human ARVCF or human p120 ctn was not found within any of our Xarvcf clones. We performed 5Ј RACE to obtain additional 5Ј sequence but were not able to identify upstream coding sequence. However, alignment of these clones did reveal alternative splicing in the 5Ј-untranslated region of Xarvcf (data not shown).
Furthermore, within the C-terminal coding sequence of Xarvcf, we found an alternative insert of 117 bp directing the synthesis of 33 additional amino acids of overall basic character (pI ϭ 9.8), and termination of the protein immediately prior to its otherwise C-terminal glycine (Fig. 1A) . This added sequence corresponds to that reported for the C-terminal sequence of human ARVCF, which, however, had not been noted to undergo alternative splicing.
We identified two alternative inserts of 15 and 18 bp, directing the synthesis of five and six additional amino acids, respectively, within the Arm domain of Xarvcf. The deletion of the 15-bp insert was found in two independent clones and is located immediately upstream of the 18-bp insert. This insert is usually present, and the alternative use of this sequence was not noted for human ARVCF. The 18-bp insert was identified in brain cDNA and has been reported for human ARVCF (38) . It is similar in sequence and location to exon C in human p120 ctn (29) . To conform with the isoform nomenclature proposed for p120 ctn (29, 52 ), Xarvcf's first start site isoform is designated Xarvcf-1, whereas its second start site isoform is designated Xarvcf-2. The alternative inserts are designated with letters in the order that the inserts were identified. The presence of Xarvcf's alternative 3Ј insert is indicated by the letter "A" following the numeric indication of the start site. For example, the Xarvcf isoform employing the first start site and possessing the 3Ј insert is designated Xarvcf-1A. Finally, with respect to use of the alternative Armadillo domain inserts, isoforms containing the 5-aa insert are designated with the letter "B" and isoforms containing the 6-aa insert are designated with the letter "C."
The cDNA coding region of Xarvcf's longest isoform (1ABC) is comprised of 2775 base pairs, which encodes 925 amino acids. Xarvcf's structural organization is similar to the known p120 ctn subfamily members in fundamental aspects, including its central Armadillo domain of 10 Armadillo repeats, with spacer sequences following repeats 4, 5, and 6 (Fig. 2) . Xarvcf's Armadillo domain is composed of 486 amino acids (1B and 2B isoforms), which are well conserved among subfamily members. Xarvcf's N and C termini, respectively, consist of 297 and 136 amino acids (1A isoform), and are less well-conserved with other p120 subfamily members, possibly contributing to the functional specificity of ARVCF orthologs. As outlined in Table  I , comparison among family members indicates that Xarvcf, as human ARVCF, is most closely related to p120 ctn . On the nucleic acid and amino acid levels, Xarvcf sequence is, respectively, 63% and 67% identical to human ARVCF, while 50% identical on the amino acid level with human p120 ctn 3. Several protein kinase consensus motifs were identified in Xarvcf, including: 1 protein kinase A site (amino acid residue 525), 16 protein kinase C sites, and 17 casein kinase II sites.
Xarvcf mRNA Expression-To determine the size and number of Xarvcf's mRNA transcripts, Northern blot analysis was performed on total RNA isolated from Xenopus oocytes. Fig. 3 shows a diffuse band migrating at approximately 6 kb, indicating that the full-length mRNA is much larger than the Xarvcf coding region. The diffuseness of the band is likely to have resulted from the comigration of distinct but closely migrating alternatively spliced transcripts.
The expression pattern of Xarvcf was evaluated by semiquantitative RT-PCR of total RNA (cDNA) isolated from the indicated embryonic stages (Fig. 4) and adult tissues (Fig. 5) . PCR primers were selected from the central non-spliced region of Xarvcf such that the combined expression level of all isoforms could be evaluated. As detected by RT-PCR, Xarvcf is a maternally provided transcript and expressed in all stages of early development (Fig. 4A, i) . In the adult, the message was detected in all tissues examined: brain, adipose, heart muscle, stomach, liver, and skin (Fig. 5A, i) .
RT-PCR was further employed to detect the presence of Xarvcf splice isoforms within the embryo. To detect isoforms arising from alternative splicing within Xarvcf's N terminus, PCR primers were selected to flank the 5Ј-spliced region noted above. As removal of the 5Ј-splice insert permits use of Xarvcf's first translational start site, generation of the smaller PCR product reflects the presence of the longer Xarvcf isoform (Xarvcf-1). Fig. 6 illustrates that, within the embryo, Xarvcf transcripts lacking the 5Ј insert are much more abundant, indicating that the upstream translational start site is likely to be more prominently utilized.
With regard to assessing the presence of the 3Ј-alternative splice isoform, which codes for 33 additional amino acids, flanking PCR indicated that it is present as a maternal transcript, as reflected in the upper band in Fig. 4A , ii. Interestingly, the abundance of this transcript decreases following gastrulation, is absent during neurulation and early tailbud stages, and establishes a low level of expression in the tadpole (Fig. 4A) . When examined in adult tissues, the 3Ј-splice isoform insert was found to be present exclusively in brain with no detectable expression in adipose, heart muscle, stomach, liver, or skin (Fig. 5A, ii) .
The expression of the Arm domain insert C was also evaluated in adult tissues, and like insert A, the presence of this 18-bp insert was found to be specific to brain tissue (Fig. 5A) . The PCR product from brain was subcloned and sequenced to verify the presence of insert C in brain Xarvcf transcripts. Insert B was present in transcripts for all of these tissues.
Xarvcf Protein Expression-To evaluate expression of the endogenous Xarvcf protein, we generated two distinct polyclonal sera directed either against Xarvcf peptides or the fulllength protein. The specificity of the antibodies was evaluated by detection of HA-epitope-tagged Xarvcf with both the anti-HA antibody and the anti-Xarvcf polyclonal antibodies (data not shown). Antibodies from both sera recognized a doublet migrating at 100 kDa in whole embryo lysates, as shown in 7, with the anti-Xarvcf peptide antibody (Fig. 7) . It was of some note that Western blot analysis of the Xarvcf protein across developmental stages indicated a decreased electrophoretic mobility during gastrulation (stages 10 -12.5), followed by a return to pregastrula mobilities during neurulation (stage 15) (Fig. 7) . As both p120 ctn and ARVCF are known to be phosphorylated, and the relative molecular weight is known to increase with phosphorylation (18, 20, 43) , it is likely that the observed electrophoretic shifts result from alterations in Xarvcf's phosphorylation status.
Xarvcf-Cadherin Association-Xarvcf interacts with fulllength C-cadherin, as demonstrated by the coimmunoprecipitation of C-cadherin-MT with Xarvcf-HA expressed in Xenopus embryos (Fig. 8A) . To determine if Xarvcf binds the cadherin juxtamembrane region utilized by other p120 subfamily members (p120 ctn and ␦-catenin), we assessed its interaction with epitope-tagged C-cadherin juxtamembrane region (aa 744 -808), directed to the plasma membrane via the src myristylation motif (47) . Co-immunoprecipitation was assessed from embryonic extracts coexpressing HA-epitope-tagged Xarvcf and Myc-epitope-tagged native or negative-control constructs of Ccadherin's juxtamembrane region (Fig. 8D) . Fig. 8B shows that Xarvcf binds C-cadherin's juxtamembrane region, while the interaction's specificity was indicated following glycine to alanine mutation of residues 771, 772, and 773, which abrogated their association. Interestingly, a juxtamembrane construct of C-cadherin that lacked the src myristylation motif and was therefore not plasma membrane-directed had only a weak interaction with Xarvcf (Fig. 8C) . Thus, as for p120 ctn and ␦-catenin, Xarvcf is a component of the cadherin complex binding to cadherin juxtamembrane regions, and this interaction is promoted by localization to the plasma membrane compartment.
DISCUSSION
In higher animal systems, including Xenopus, the cadherincatenin complex participates in effecting early morphogenic events such as the coalescence of cells expressing the same cadherin type into rudimentary masses, and subsequently, the more defined junctional organization characteristic of differentiated tissues. Functional perturbation of the cadherin-catenin complex invariably makes evident its essential roles in cell-cell adhesion and motility processes taking place within the embryo and adult, and in maintaining differentiated cell fates. Thus, the physiologic and often dynamic regulation of cadherin function is believed to be central to cell adhesion and motility within the embryo and adult, and its disregulation to the progression of disease. Analogous to integrin-dependent cell-substrate interactions, cadherin-mediated cell-cell adhesion and motility is responsive to interactions with the associated cortical cytoskeleton and likely to additional cofactors such as catenins contributing to higher-order cadherin organization within the membrane plane.
We report here the cloning and characterization of Xenopus ARVCF, Xarvcf, and demonstrate its capacity to bind the juxtamembrane region of cadherin. Differential mRNA splicing produces at least four isoforms of Xarvcf, one or more of which are present maternally and throughout development, and within a diversity of adult Xenopus tissues. Of the two alternative translational start sites, the upstream ATG is the more commonly utilized, and aligns with the shorter of the human ARVCF isoforms. The second and less commonly utilized translational start for Xarvcf was not reported for human ARVCF, and is homologously positioned with the third translational start site of human p120 ctn . Because human p120 ctn and human ARVCF have additional well conserved coding sequence upstream of the first translational start sites resolved for Xarvcf, which we have sought but not yet isolated, it is possible that additional Xarvcf sequence (82 amino acids for human FIG. 6 . RT-PCR analysis of alternative splicing at the amino terminus of the Xarvcf transcript. Start site 1 is preferred over start site 2 as made evident via RT-PCR. When the insert is present, a product of 570 bp is generated, and, when absent, a PCR product of 492 bp is produced. Removal of the insert eliminates stop codons residing between start site 1 and the ORF, thereby permitting use of start site 1.
FIG. 7.
Immunoblot analysis of Xarvcf protein at the indicated embryonic stages. Xarvcf protein in total embryo extracts isolated in the presence of phosphatase inhibitors was detected using affinitypurified anti-Xarvcf peptide polyclonal antibody. The anti-Xarvcf antibody recognizes two major bands at about 100 kDa, the upper band being the most prominent. There is a shift in gel mobility of Xarvcf protein in early development, increasing during cleavage stages (stage 5) and decreasing during gastrulation (stages 10 -12.5), likely reflecting developmentally regulated post-translational modification to Xarvcf.
FIG. 8. Xarvcf binds to the juxtamembrane region of C-cadherin.
A, embryos were injected with mRNA coding for Xarvcf-HA (isoform 1B was used for all of these experiments with hemagglutinin epitope tag) and C-cadherin-MT (myc epitope tag) and were immunoblotted for C-cadherin-MT and Xarvcf-HA following immunoprecipitation of Xarvcf-HA. B, embryos were injected with mRNA coding for Xarvcf-HA and either the membrane targeted C-cadherin JMR-Myr.MT or the mutant C-cadherin JMRGA-Myr.MT. Following immunoprecipitation of C-cadherin JMR-Myr.MT or C-cadherin JMRGA-Myr.MT, the coimmunoprecipitation of Xarvcf-HA protein was detected from Xenopus whole embryo lysates blotted with anti-HA monoclonal antibody. Xarvcf coimmunoprecipitates with membrane-targeted C-cadherin JMR-Myr.MT but not with the mutant construct JMRGA-Myr.MT. C, embryos were injected with mRNA coding for Xarvcf-HA and either the membrane-targeted C-cadherin JMR-Myr.MT or the non-membranetargeted C-cadherin JMR-MT, lacking the myristylation motif. Immunoprecipitation of JMR-Myr.MT and JMR-MT followed by immunoblotting for Xarvcf-HA showed that the interaction of Xarvcf is stronger with the membrane-localized construct. D, the sequence of the juxtamembrane domain of C-cadherin used to test the interaction of Xarvcf with C-cadherin. The boxed glycine residues were mutated to alanines for the construct JMRGA-Myr.MT. ARVCF) resides upstream of that which we report.
In addition to alternative translational initiation, we detected an alternative coding insert of 33 amino acids within the C-terminal region of Xarvcf (Xarvcf A). The insert sequence aligns with homologous C-terminal sequence reported for human ARVCF, although alternative splicing in this region was not noted for the human transcript. Interestingly, Xarvcf A is developmentally regulated. The transcript is present maternally and persists into early gastrulation, a stage during which the embryo initiates morphogenesis and, presumably, modulation of cadherin-dependent adhesion and motility. The Xarvcf A transcript decreases by late gastrulation and is absent during neurulation, during which time the embryo continues to engage in cell movements resulting in the embryo's axial elongation.
Strikingly, in the adult, Xarvcf A appears to be restricted to the brain, which may account for its detectable low level reexpression at the tadpole stage. Likewise, the alternative insert Xarvcf C is also restricted to brain. Although possible functional consequences are unclear at present, there is precedence for neural-specific expression of p120 ctn subfamily members and isoforms. For example, human p120 ctn exon C is neural-specific (29, 53) . Furthermore, ␦-catenin, a member of the p120 ctn subfamily, displays restricted neural expression (31, 32) and, in addition to binding the juxtamembrane region of cadherin, associates with presenilin (32) and S-SCAM (synaptic scaffolding molecule) (54) . Thus, in addition to potentially distinctive roles of Xarvcf isoforms within the same cell or tissue, it is conceivable that differential expression across distinct cell and tissue types contributes to the specialized modulation of cadherin-based adhesion and motility, for example, which may be required within neurons.
Human ARVCF was initially identified as a p120 ctn subfamily member based solely upon shared sequence homology. Because we have shown that Xarvcf binds the cadherin juxtamembrane region utilized by p120 ctn (13, 15, 16) , and ␦-catenin (17) , and that Arm domain repeats 1-10 are sufficient for the interaction (data not shown), it is likely that the ARVCF orthologs of other species similarly associate with cadherin via their central Armadillo domains, characteristic of bona fide "catenins." With respect to Xarvcf, we went on to demonstrate the specificity of its interaction with the cadherin juxtamembrane region via site-directed mutagenesis of C-cadherin's juxtamembrane region (glycine 771, 772, 773 to alanine 771, 772, 773), resulting in the loss of their association and that membrane localization of the C-cadherin JMR greatly increases association of Xarvcf with the JMR.
Xarvcf's association with the cadherin juxtamembrane region, and homology with other p120 ctn subclass of catenins, highlights its possible modulation of cadherin-based adhesion and motility. As previously noted, the p120 ctn subclass members p120 ctn and ␦-catenin have been implicated in regulatory effects upon cadherin and cytoskeletal function. Published work includes findings that the exogenous expression of native E-cadherin increased cell-cell adhesion, whereas juxtamembrane region mutants incapable of associating with p120 ctn displayed severely reduced adhesion capacities (20) . With regard to cytoskeletal effects, transfection of mouse p120 ctn resulted in dramatic actin microfilament rearrangements within fibroblasts, a response not seen following the introduction of p120 ctn negative control constructs or of ␤-catenin (55). Likewise, when expressed in polarized epithelial (Madin-Darby canine kidney) cells, ␦-catenin increased hepatocyte growth factor-induced cell motility (17) , while disrupting cadherin-based (zonula adherens) and tight junctional integrity. Finally, in animal systems, the exogenous expression of mouse p120 ctn in early Xenopus embryos resulted in anterior abnormalities and failed gastrulation (19, 56) , arising apparently from decreased cadherin-mediated cell-cell adhesion (19) .
Because the forced lateral dimerization/clustering of membrane-tethered cadherin extracellular domains was earlier shown sufficient in achieving strong cell-cell adhesion, we were interested in identifying native cadherin domains capable of supporting such dimerization/clustering (57) . Such an activity was mapped to the cadherin juxtamembrane region, which was further discovered to associate with p120 ctn , and resulted in the proposition that p120 ctn positively effects cadherin dimerization and/or clustering (11, 13) . Opposing conclusions, however, have been derived from groups transfecting E-cadherin constructs into cadherin-deficient cell lines, wherein constructs retaining the juxtamembrane region displayed reduced cadherin dimerization and adhesive activity (12, 14, 18) .
Although the underlying bases of such discrepancies are not yet known, likely possibilities include physiologic control of post-translational modifications to the cadherin juxtamembrane region and/or to p120 ctn subfamily members, switching one or both between positive and negative effector states. Indeed, the p120 ctn subfamily of proteins becomes highly phosphorylated in response to a variety of cellular stimuli (58 -61) in correlation with altered cell adhesion and motility (16, 62, 63) . Furthermore, the inhibition of phosphorylation, or deletion of domains containing putative phosphorylation sites within p120 ctn increases cadherin adhesive activity (14, 18) . We find it intriguing in this regard that the electrophoretic mobility of Xarvcf varies across Xenopus developmental stages, which conceivably might reflect physiologic changes in its phosphorylation status and thereby functionality in the modulation of cadherin-based adhesion and/or motility.
It will be important to further investigate Xarvcf's developmental roles by applying loss-of-function (antisense) and dominant negative approaches and to characterize the functional consequences of differential isoform usage and putative phosphorylation status. Of particular interest is the correlation of Xarvcf's cellular and developmental phenotypes with the underlying molecular mechanisms modulating cadherin lateral dimerization/oligomerization.
